Genomic alterations associated with resistance to EGFR monoclonal antibodies (mAb) in real-world patients with metastatic colorectal cancer (mCRC).

被引：0
|
作者：
Klempner, Samuel J.
Quintanilha, Julia C. F. C. F.
Emmett, Matthew
Graf, Ryon
Schrock, Alexa Betzig
Tukachinsky, Hanna
Oxnard, Geoffrey R.
Myer, Parvathi
机构：
[1] Massachusetts Gen Hosp, Boston, MA USA
[2] Fdn Med Inc, Boston, MA USA
[3] Dana Farber Canc Inst, Boston, MA USA
[4] Fdn Med Inc, Cambridge, MA USA
[5] Albert Einstein Canc Ctr, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
52
引用
收藏
页码：52 / 52
页数：1
相关论文
共 50 条
  • [41] Abnormal hair growth in patients (pts) with metastatic colorectal cancer (mCRC) treated with the anti-epidermal growth factor receptor (EGFr) monoclonal antibody (mAb) panitumumab (Pmab)
    Tubb, E. E.
    Nugent, M.
    Spielberger, J.
    Axelrod, R. A.
    Mitchell, E. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [42] Anti-EGRF Monoclonal Antibodies and Surgery of Metastases in the Treatments of Metastatic Colorectal Cancer (mCRC)
    Kit, O.
    Vladimirova, L.
    Abramova, N.
    Storozhakova, A.
    Popova, I.
    Tikhanovskaya, N.
    Novoselova, K.
    ANNALS OF ONCOLOGY, 2016, 27 : 42 - 42
  • [43] Real-world evidence on genomic profiles and survival outcomes in patients with HER2-positive metastatic colorectal cancer
    Matsubara, Yuki
    Bando, Hideaki
    Nakamura, Yoshiaki
    Misumi, Toshihiro
    Ng, Dionne
    Tajima, Eri
    Pittell, Harlan
    Yoshino, Takayuki
    Ohtsu, Atsushi
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 58 - 58
  • [44] Real-World Outcomes of Anti-EGFR Rechallenge Guided by Liquid Biopsy in Metastatic Colorectal Cancer
    Roque, Ricardo
    Santos, Rita Antunes
    Santos, Luis Guilherme
    Coelho, Rita
    Fernandes, Isabel Viera
    Cunha, Goncalo
    Goncalves, Marta
    Paulo, Judy
    Bonito, Nuno
    GE PORTUGUESE JOURNAL OF GASTROENTEROLOGY, 2025,
  • [45] INCREASED SENSITIVITY OF K-RAS MUTATIONS DETECTION ENHANCES PREDICTION OF CLINICAL RESISTANCE TO ANTI-EGFR MONOCLONAL ANTIBODIES (MOABS) IN METASTATIC COLORECTAL CANCER (MCRC)
    De Dosso, Sara
    Molinari, Francesca
    Felicioni, Lara
    Buscarino, Michela
    Buttitta, Fiamma
    Malatesta, Sara
    Saletti, Piercarlo
    Crippa, Stefano
    Mazzucchelli, Luca
    Marchetti, Antonio
    Bardelli, Alberto
    Frattini, Milo
    ANNALS OF ONCOLOGY, 2009, 20
  • [46] Dissecting primary resistance to anti-EGFR monoclonal antibodies (anti-EGFRs) in RAS and BRAF wild-type (wt) metastatic colorectal cancer (mCRC)
    Cremolini, Chiara
    Berenato, Rosa
    Morano, Federica
    Moretto, Roberto
    Perrone, Federica
    Tamborini, Elena
    Rossini, Daniele
    Gloghini, Annunziata
    Busico, Adele
    Fuca, Giovanni
    Baratelli, Chiara
    Tamburini, Emiliano
    Capone, Iolanda
    Volpi, Chiara Costanza
    Milione, Massimo
    Di Maio, Massimo
    Fontanini, Gabriella
    De Braud, Filippo
    Falcone, Alfredo
    Pietrantonio, Filippo
    CANCER RESEARCH, 2017, 77
  • [47] Understanding of metastatic colorectal cancer (mCRC) in the real world: Initial results from a European survey on the unmet needs of patients living with metastatic colorectal cancer
    Maravic, Z.
    Wyrwicz, L.
    Karczmarek-Borowska, B.
    Basany, E. Espin
    Carrato, A.
    Horvath, A.
    aBenedict
    Kapitany, Z.
    ANNALS OF ONCOLOGY, 2018, 29 : 77 - 77
  • [48] Real-world dosing of regorafenib in metastatic colorectal cancer (mCRC): Interim analysis from the prospective, observational CORRELATE study
    Manuel, O'Connor Juan
    Leopold, Oehler
    Werner, Scheithauer
    Jean-Philippe, Metges
    Louis-Marie, Dourthe
    Willem, de Groot Jan
    Josef, Thaler
    Kun-Huei, Yeh
    Jen-Kou, Lin
    Alfredo, Falcone
    Punt, Cornelis J. A.
    Jan, Kalinovsky
    Sabine, Fiala-Buskies
    Andres, Cervantes
    Petersen, Lone N.
    Michel, Ducreux
    ANNALS OF ONCOLOGY, 2017, 28
  • [49] Real-World Data: Fruquintinib in Treating Metastatic Colorectal Cancer
    Liu, Shuai
    Lu, Lu
    Pan, Feng
    Yang, Chunsheng
    Liang, Jing
    Liu, Jinfeng
    Wang, Jian
    Shen, Rong
    Xin, Fu-Ze
    Zhang, Nan
    ONCOLOGY RESEARCH, 2021, 29 (01) : 25 - 31
  • [50] Impact of time to treatment initiation on real-world (RW) outcomes in metastatic colorectal cancer (mCRC) in the United States.
    Gbolahan, Olumide B.
    Outlaw, Darryl Alan
    Hashemi, Neda
    Paluri, Ravi Kumar
    Williams, Grant Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345